Marco A Ciufolini

USPTO Granted Patents = 16 (Patent Applications = 26)

CIPO Patents = 8 (Patent Applications = 12)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 134(Granted Patents)

Company Filing History:

9 out of 932

The University of British Columbia

patents

2 out of 14

Tekmira Pharmaceuticals Corporation

Arbutus Biopharma Corporation

patents

5. 1 out of 81

Pierre Fabre Dermo-cosmetique

patents

6. 1 out of 5,089

Centre National De La Recherche Scientifique

patents

7. 1 out of 210

Universite Claude Bernard – Lyon1

patents

8. 1 out of 5

Nanovation Therapeutics Inc.

patents

9. 1 out of 5

Aviragen Therapeutics, Inc.

patents

10. 1 out of 2

Obe Therapy Biotechnology

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121591 - Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents (2024-10-22),

2. 10780174 - Lipid-linked prodrugs (2020-09-22),

3. 10653780 - Amino lipids and methods for the delivery of nucleic acids (2020-05-19),

4. 9968554 - Modified drugs for use in liposomal nanoparticles (2018-05-15),

5. 9908858 - Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus (2018-03-06),

6. 9481709 - Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism (2016-11-01),

7. 9139554 - Amino lipids and methods for the delivery of nucleic acids (2015-09-22),

8. 8993573 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2015-03-31),

9. 8835435 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2014-09-16),

10. 8790691 - Modified drugs for use in liposomal nanoparticles (2014-07-29),

11. 8722082 - Lipids and compositions for the delivery of therapeutics (2014-05-13),

12. 8568772 - Modified drugs for use in liposomal nanoparticles (2013-10-29),

13. 8545877 - Modified drugs for use in liposomal nanoparticles (2013-10-01),

14. 8545876 - Modified drugs for use in liposomal nanoparticles (2013-10-01),

15. 8324410 - Modified drugs for use in liposomal nanoparticles (2012-12-04),

Title: Inventor Marco A Ciufolini - Revolutionizing Technology in Vancouver, CA

Introduction: Marco A Ciufolini is a visionary inventor based in Vancouver, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Marco A Ciufolini holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more efficient and eco-friendly future.

Career Highlights: With a career spanning over two decades, Marco A Ciufolini has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Marco A Ciufolini has collaborated with top engineers, scientists, and researchers, pooling their expertise to push the boundaries of what is possible in the world of technology.

Conclusion: Marco A Ciufolini's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Vancouver and beyond.

This text is generated by artificial intelligence and may not be accurate.